NewsRoom

鼎康生物与Y’s AC达成战略合作,共同推进抗CD26单克隆抗体在难治性肿瘤中的临床开发

(English) Inside the partnership between Chime Biologics and Polpharma Biologics International

鼎康生物与魔境生物达成战略合作,共同推进AI赋能生物药全生命周期智能制造

Chime Biologics Live Fireside Chat

百亿美元交易的背后:商业化生产权益正在成为中国生物药对外授权交易的新价值密码

(English) Can New Entrants Win the Biosimilar Race? What Europe's Biosimilar Market Reveals About the Next Competitive Frontier

categoryidArraymk-test